These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38850023)

  • 1. Biomarkers for gene therapy clinical trials of lysosomal storage disorders.
    Rossi A; Malvagia S; la Marca G; Parenti G; Brunetti-Pierri N
    Mol Ther; 2024 Jun; ():. PubMed ID: 38850023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in Lysosomal Storage Diseases.
    Bobillo Lobato J; Jiménez Hidalgo M; Jiménez Jiménez LM
    Diseases; 2016 Dec; 4(4):. PubMed ID: 28933418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in gene therapy for lysosomal storage disorders.
    Rastall DP; Amalfitano A
    Appl Clin Genet; 2015; 8():157-69. PubMed ID: 26170711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement.
    Sevin C; Deiva K
    Front Mol Biosci; 2021; 8():624988. PubMed ID: 34604300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on gene therapy for lysosomal storage disorders.
    Nagree MS; Scalia S; McKillop WM; Medin JA
    Expert Opin Biol Ther; 2019 Jul; 19(7):655-670. PubMed ID: 31056978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
    Haskins M
    ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for lysosomal storage diseases: Current clinical trial prospects.
    Kido J; Sugawara K; Nakamura K
    Front Genet; 2023; 14():1064924. PubMed ID: 36713078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S; Viéitez I; Navarro C; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.
    Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P
    Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review.
    Vuolo D; Do Nascimento CC; D'Almeida V
    Front Mol Biosci; 2021; 8():773384. PubMed ID: 34869599
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.
    Dardis A; Buratti E
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29415500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.
    Elmonem MA; Abdelazim AM
    Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases.
    Rintz E; Higuchi T; Kobayashi H; Galileo DS; Wegrzyn G; Tomatsu S
    Mol Ther Methods Clin Dev; 2022 Mar; 24():71-87. PubMed ID: 34977274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal storage diseases: Stem cell-based cell- and gene-therapy.
    Kim SU
    Cell Transplant; 2014 May; ():. PubMed ID: 24853878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.
    Mohamed FE; Al-Gazali L; Al-Jasmi F; Ali BR
    Front Pharmacol; 2017; 8():448. PubMed ID: 28736525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytes and lysosomal storage diseases.
    Rama Rao KV; Kielian T
    Neuroscience; 2016 May; 323():195-206. PubMed ID: 26037807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.